So basically we are saying Otsuka needs us than we need them?
For Dec to replace Dox (or other drugs) in solid tumours, Otsuka (or other pharma) would need to run their own trials and not jump in with in our all-comers trial or such, correct? So apart from proving what we already know about Bis+ Dec in our upcoming AML trials how can progress this further @RaceOncology? Thanks
So basically we are saying Otsuka needs us than we need them?For...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.62 |
Change
0.035(2.21%) |
Mkt cap ! $276.1M | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.62 | $1.57 | $54.80K | 34.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4400 | $1.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.63 | 659 | 1 |
View Market Depth
| Last trade - 14.08pm 06/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |